Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 35, Issue 3, Pages 149–154
http://dx.doi.org/10.1155/2013/787130
Research Article

Glycophenotype Evaluation in Cutaneous Tumors Using Lectins Labeled with Acridinium Ester

1Laboratório de Imunopatologia Keizo Asami (LIKA), Universidade Federal de Pernambuco, Cidade Universitária, 50030 Recife, PE, Brazil
2Faculdade de Ciências, Educação e Tecnologia de Garanhuns (FACETEG), Universidade de Pernambuco (UPE), 50100 Garanhuns, PE, Brazil
3Departamento de Bioquímica, Universidade Federal de Pernambuco, Cidade Universitária, 50030 Recife, PE, Brazil

Received 27 March 2013; Revised 13 June 2013; Accepted 21 June 2013

Academic Editor: Timothy M. Block

Copyright © 2013 Luiza Rayanna Amorim Lima et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Ghazarian, B. Idoni, and S. B. Oppenheimer, “A glycobiology review: carbohydrates, lectins and implications in cancer therapeutics,” Acta Histochemica, vol. 113, no. 3, pp. 236–247, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. B. Adamczyk, T. Tharmalingam, and P. M. Rudd, “Glycans as cancer biomarkers,” Biochimica et Biophysica Acta, vol. 1820, no. 9, pp. 1347–1353, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. Y. Mechref, Y. Hu, A. Garcia, and A. Hussein, “Identifying cancer biomarkers by mass spectrometry-based glycomics,” Electrophoresis, vol. 33, no. 12, pp. 1755–1767, 2012. View at Publisher · View at Google Scholar
  4. M. M. Fuster and J. D. Esko, “The sweet and sour of cancer: glycans as novel therapeutic targets,” Nature Reviews Cancer, vol. 5, no. 7, pp. 526–542, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Herling, J. Knolle, H. Bahn et al., “Glycohistochemical monitoring of chemically induced sarcomas at different stages of tumorigenesis,” In Vivo, vol. 14, no. 4, pp. 499–506, 2000. View at Google Scholar · View at Scopus
  6. A. Thies, I. Moll, J. Berger, and U. Schumacher, “Lectin binding to cutaneous malignant melanoma: HPA is associated with metastasis formation,” British Journal of Cancer, vol. 84, no. 6, pp. 819–823, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Thies, A. Berlin, G. Brunner et al., “Glycoconjugate profiling of primary melanoma and its sentinel node and distant metastases: implications for diagnosis and pathophysiology of metastases,” Cancer Letters, vol. 248, no. 1, pp. 68–80, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. M. R. Melo Júnior, J. L. S. Araújo Filho, V. J. R. M. Patu, M. C. F. P. Machado, E. I. C. Beltrão, and L. B. Carvalho Jْnior, “Digital image analysis of skin neoplasms evaluated by lectin histochemistry: potential marker to biochemical alterations and tumour differential diagnosis,” Jornal Brasileiro de Patologia e Medicina Laboratorial, vol. 42, no. 6, pp. 455–460, 2006. View at Publisher · View at Google Scholar
  9. T. Basarab, G. Orchard, and R. Russell-Jones, “The use of immunostaining for bcl-2 and CD34 and the lectin peanut agglutinin in differentiating between basal cell carcinomas and trichoepitheliomas,” American Journal of Dermatopathology, vol. 20, no. 5, pp. 448–452, 1998. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Roda, M. Mirasoli, D. Melucci, and P. Reschiglian, “Toward multianalyte immunoassays: a flow-assisted, solid-phase format with chemiluminescence detection,” Clinical Chemistry, vol. 51, no. 10, pp. 1993–1995, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. J. L. S. Araújo Filh, M. R. Melo Júnior, and L. B. Carvalho Júnior, “Potential applications of the chemiluminescent methods in tumoral diseases investigation,” International Journal of Pharma & Bio Sciences, vol. 2, no. 2, pp. 392–400, 2011. View at Google Scholar
  12. A. Natrajan, D. Sharpe, J. Costello, and Q. Jiang, “Enhanced immunoassay sensitivity using chemiluminescent acridinium esters with increased light output,” Analytical Biochemistry, vol. 406, no. 2, pp. 204–213, 2011. View at Publisher · View at Google Scholar
  13. J. Plzák, K. Smetana Jr., M. Chovanec, and J. Betka, “Glycobiology of head and neck squamous epithelia and carcinomas,” Oto-Rhino-Laryngolog, vol. 67, no. 2, pp. 61–69, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Fan, Z. Cao, H. Li, M. Kai, and J. Lu, “Chemiluminescence platforms in immunoassay and DNA analyses,” Analytical Sciences, vol. 25, no. 5, pp. 587–597, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. V. P. Brustein, C. L. B. Cavalcanti, M. R. Melo Júnior, M. T. Correia, E. I. C. Beltrão, and L. B. Carvalho Júnior, “Chemiluminescent detection of carbohydrates in the tumoral breast diseases,” Applied Biochemistry and Biotechnology, vol. 166, no. 2, pp. 268–275, 2011. View at Publisher · View at Google Scholar
  16. L. J. Kricka, “Clinical applications of chemiluminescence,” Analytica Chimica Acta, vol. 500, no. 1-2, pp. 279–286, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. D. W. King, W. J. Cooper, S. A. Rusak et al., “Flow injection analysis of H2O2 in natural waters using acridinium ester chemiluminescence: method development and optimization using a kinetic model,” Analytical Chemistry, vol. 79, no. 11, pp. 4169–4176, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Ricotti, N. Bouzari, A. Agadi, and C. J. Cockerell, “Malignant skin neoplasms,” Medical Clinics of North America, vol. 93, no. 6, pp. 1241–1264, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. E. I. Beltrão, M. T. S. Correia, J. F. Silva, and L. C. B. B. Coelho, “Binding evaluation of Isoform 1 from Cratyliamollislectin to human mammary tissues,” Applied Biochemistry and Biotechnology, vol. 74, no. 3, pp. 125–134, 1998. View at Google Scholar
  20. O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall, “Protein measurement with the Folin phenol reagent,” The Journal of Biological Chemistry, vol. 193, no. 1, pp. 265–275, 1951. View at Google Scholar · View at Scopus
  21. R. A. L. Coêlho, G. A. Jaques, A. D. Barbosa et al., “Magnetic polysiloxane-polyvinyl alcohol composite as solid-phase in chemiluminescent assays,” Biotechnology Letters, vol. 24, no. 20, pp. 1705–1708, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. L. M. Campos, C. L. B. Cavalcanti, J. L. Lima-Filho, L. B. Carvalho, and E. I. C. Beltrão, “Acridinium ester conjugated to lectin as chemiluminescent histochemistry marker,” Biomarkers, vol. 11, no. 5, pp. 480–484, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. M. J. B. M. Rêgo, M. F. Cordeiro, C. L. B. Cavalcanti, L. B. Carvalho Júnior, and E. I. C. Beltrão, “Imunohistoquimiluminescence detection: a quantitative tool in breast cancer HER-2 status evaluation,” Disease Markers, vol. 34, no. 5, pp. 373–377, 2013. View at Publisher · View at Google Scholar
  24. S. M. Zhou, L. Cheng, S. J. Guo, H. Zhu, and S. C. Tao, “Lectin microarrays: a powerful tool for glycan-based biomarker discovery,” Combinatorial Chemistry and High Throughput Screening, vol. 14, no. 8, pp. 711–719, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. B. Schnegelsberg, U. Schumacher, and U. Valentiner, “Lectin histochemistry of metastasizing and non-metastasizing breast and colon cancer cells,” Anticancer Research, vol. 31, no. 5, pp. 1589–1597, 2011. View at Google Scholar · View at Scopus
  26. N. D. S. Rambaruth and M. V. Dwek, “Cell surface glycan-lectin interactions in tumor metastasis,” Acta Histochemica, vol. 113, no. 6, pp. 591–600, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. B. T. Jamal, M. Nita-Lazar, Z. Gao, B. Amin, J. Walker, and M. A. Kukuruzinska, “N-glycosilation status of E-cadherin controls cytoskeletal dynamics through the organization of distinct β-catenin and γ-catenin-containing AJs,” Journal of Cell Health and Cytoskeleton, vol. 2009, no. 1, pp. 67–80, 2009. View at Google Scholar
  28. K. Smetana Jr., J. Plzák, B. Dvoránková, and Z. Holíková, “Functional consequences of the glycophenotype of squamous epithelia—practical employment,” Folia Biologica, vol. 49, no. 3, pp. 118–127, 2003. View at Google Scholar
  29. Y. J. Kim and A. Varki, “Perspectives on the significance of altered glycosylation of glycoproteins in cancer,” Glycoconjugate Journal, vol. 14, no. 5, pp. 569–576, 1997. View at Publisher · View at Google Scholar · View at Scopus
  30. A. S. Powlesland, P. G. Hitchen, S. Parry et al., “Targeted glycoproteomic identification of cancer cell glycosylation,” Glycobiology, vol. 19, no. 8, pp. 899–909, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. Takenaka, T. Fukumori, and A. Raz, “Galectin-3 and metastasis,” Glycoconjugate Journal, vol. 19, no. 7–9, pp. 543–549, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. E. Miyoshi, K. Moriwaki, and T. Nakagawa, “Biological function of fucosylation in cancer biology,” Journal of Biochemistry, vol. 143, no. 6, pp. 725–729, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. K. Moriwaki and E. Miyoshi, “Fucosylation and gastrointestinal cancer,” World Journal of Hepatology, vol. 2, no. 4, pp. 151–161, 2010. View at Publisher · View at Google Scholar
  34. Y. Zhao, S. Itoh, X. Wang et al., “Deletion of core fucosylation on α3β1 integrin down-regulates its functions,” Journal of Biological Chemistry, vol. 281, no. 50, pp. 38343–38350, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. D. Osumi, M. Takahashi, E. Miyoshi et al., “Core fucosylation of E-cadherin enhances cell-cell adhesion in human colon carcinoma WiDr cells,” Cancer Science, vol. 100, no. 5, pp. 888–895, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. F. Lehmann, E. Tiralongo, and J. Tiralongo, “Sialic acid-specific lectins: occurrence, specificity and function,” Cellular and Molecular Life Sciences, vol. 63, no. 12, pp. 1331–1354, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. N. M. Varki and A. Varki, “Diversity in cell surface sialic acid presentations: implications for biology and disease,” Laboratory Investigation, vol. 87, no. 9, pp. 851–857, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. W. Bergler, F. Riedel, R. Schwartz-Albiez, H. J. Gross, and K. Hörmann, “A new histobiochemical method to analyze sialylation on cell-surface glycoproteins of head and neck squamous-cell carcinomas,” European Archives of Oto-Rhino-Laryngology, vol. 254, no. 9-10, pp. 437–441, 1997. View at Google Scholar · View at Scopus
  39. P. Vural, M. Canbaz, and D. Selçuki, “Total and lipid-bound Sialic acid levels in actinic keratosis and basal cell carcinoma,” Turkish Journal of Medical Sciences, vol. 29, pp. 419–423, 1999. View at Google Scholar
  40. S. I. Hakamory, “Tumor-associated carbohydrate antigens,” Annual Review of Immunology, vol. 2, pp. 103–126, 1984. View at Publisher · View at Google Scholar
  41. K. L. Carraway, N. Fregien, K. L. Carraway III, and C. A. C. Carraway, “Tumor sialomucin complexes as tumor antigens and modulators of cellular interactions and proliferation,” Journal of Cell Science, vol. 103, no. 2, pp. 299–307, 1992. View at Google Scholar · View at Scopus